GILD

Gilead Sciences, Inc. NMS · GILD

$134.28 -2.02 (-1.48%)

Neutral · +0.86σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $166.7B

P/E (ttm) 18.3

Forward P/E 13.8

Beta (5y) 0.34

Shares out 1,241.6M

Div yield 2.44%

Profitability & returns

ROE 43.4%

Net margin 31.0%

FCF margin 26.7%

Debt / equity 0.95

Trading information

Last price $134.28

Day range $134.09 – $140.61

52-wk range $121.39 – $157.29

Avg volume 7.5M

RSI (2) 54.6

Trend zone Neutral

52-week range · today's price

$121.39$157.29

Company

Sector Healthcare

Industry Drug Manufacturers - General

Exchange NMS

Next earnings 2026-08-06

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary bi…